Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.11
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT - Market closed

TDAC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Selling, General & Admin
0.20.490.07
Operating Expenses
0.20.490.07
Operating Income
-0.2-0.49-0.07
Interest & Investment Income
0.13--
Pretax Income
-0.07-0.49-0.07
Net Income
-0.07-0.49-0.07
Net Income to Common
-0.07-0.49-0.07
Shares Outstanding (Basic)
444
Shares Outstanding (Diluted)
444
Shares Change (YoY)
8.46%--
EPS (Basic)
-0.02-0.12-0.02
EPS (Diluted)
-0.02-0.12-0.02
EBIT
-0.2-0.49-0.07
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q